Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES

  • Read more about PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES
United Kingdom
95941444.2
Filed on 1995-11-20

Cell Membrane-specific Epitopes On CD30: Potentially Superior Targets For Immunotherapy

  • Read more about Cell Membrane-specific Epitopes On CD30: Potentially Superior Targets For Immunotherapy
Patent Cooperation Treaty
PCT/US2006/019128
Filed on 2006-05-16

MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES

  • Read more about MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES
European Patent
04812188.3
Filed on 2004-11-24

MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES

  • Read more about MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES
Japan
2006-541725
Filed on 2004-11-24

MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES

  • Read more about MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES
Australia
2004293471
Filed on 2004-11-24

MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES

  • Read more about MUTATED ANTI-CD-22 ANTIBODIES AND IMMUNOCONJUGATES
Canada
2547165
Filed on 2004-11-25

Improvements To BL22 Immunotoxin

  • Read more about Improvements To BL22 Immunotoxin
US Patent 7,982,011
Filed on 2006-05-25

Modified HCV Peptide Immunogens

  • Read more about Modified HCV Peptide Immunogens
US Patent 7,341,726
Filed on 2006-05-05

Biologically Active Macrolides, Compositions, and Uses Thereof

  • Read more about Biologically Active Macrolides, Compositions, and Uses Thereof
US Patent 7,790,764
Filed on 2006-05-16

NEURONALLY EXPRESSED STEM CELL FACTOR MODULATES ANGIOGENESIS AND NEURAL STEM CELL MIGRATION TO AREAS OF BRAIN INJURY

  • Read more about NEURONALLY EXPRESSED STEM CELL FACTOR MODULATES ANGIOGENESIS AND NEURAL STEM CELL MIGRATION TO AREAS OF BRAIN INJURY
US Application 11/440,173
Filed on 2006-05-24

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 990
  • Page 991
  • Page 992
  • Page 993
  • Page 994
  • Page 995
  • Page 996
  • Page 997
  • Page 998
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health